Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Recurrence 1Prostatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Glioma 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Endometrial Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Carcinoma 1Breast Neoplasms 1Biliary Tract Neoplasms 1Bile Duct Neoplasms 1Advanced Breast Cancer 1

Interventions

Letrozole 5Fulvestrant 5trastuzumab deruxtecan 3Injections 3toripalimab 2sacituzumab govitecan 2palbociclib 2elacestrant 2abemaciclib 2Anastrozole 2AZD9833 2ribociclib 1pyrotinib 1exemestane 1eribulin 1disitamab vedotin 1dalpiciclib 1Vinorelbine 1Selective Estrogen Receptor Modulators 1Ritonavir 1RAD1901 1Paclitaxel 1Lead 1Itraconazole 1Goserelin 1Gonadotropin-Releasing Hormone 1Everolimus 1Docetaxel 1Bevacizumab 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Breast Cancer × Ritonavir × 1 year × Clear all
NCT06710990 2026-06-04

Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in Subjects With HER2-expressing Advanced Breast Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 1 Completed
17 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡